Related Experiment Videos
Partial V(D)J recombination activity leads to Omenn syndrome
A Villa1, S Santagata, F Bozzi
1Department of Human Genome and Multifactorial Disease, Istituto di Tecnologie Biomediche Avanzate, Consiglio Nazionale delle Ricerche, Segrate (Milano) Italy.
Cell
|June 18, 1998
Summary
Omenn syndrome, a severe immunodeficiency, is linked to partial activity of Rag-1 and Rag-2 proteins due to missense mutations. These mutations impair V(D)J recombination, impacting immune cell development and function.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- Genomic rearrangement of antigen receptor loci is initiated by lymphoid-specific proteins Rag-1 and Rag-2.
- Null mutations in Rag-1 or Rag-2 lead to severe combined immunodeficiency (SCID) with absent mature B and T lymphocytes.
Purpose of the Study:
- Investigate the genetic basis of Omenn syndrome, a severe immunodeficiency.
- Determine how mutations in Rag-1 and Rag-2 genes contribute to Omenn syndrome pathogenesis.
Main Methods:
- Analysis of Rag-1 and Rag-2 genes in patients with Omenn syndrome.
- Characterization of amino acid substitutions and their impact on protein function (DNA binding, protein interaction).
Main Results:
- Patients with Omenn syndrome harbor missense mutations in Rag-1 or Rag-2 genes, resulting in partially active proteins.
- Specific mutations decrease Rag-1 DNA binding activity and/or reduce Rag-1/Rag-2 interaction efficiency.
- These molecular defects impair V(D)J recombination initiation.
Conclusions:
- Omenn syndrome arises from mutations that compromise V(D)J recombination efficiency.
- Partial loss-of-function mutations in Rag proteins cause a distinct immunodeficiency phenotype.
- Understanding these mechanisms is crucial for diagnosing and potentially treating Omenn syndrome.